|
Volumn 21, Issue 3, 2001, Pages 215-223
|
Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment
|
Author keywords
Bcl 2; Kainate; Melatonin; Neuroprotection; Nigrostriatal pathway
|
Indexed keywords
KAINIC ACID;
MELATONIN;
PROTEIN BCL 2;
TYROSINE 3 MONOOXYGENASE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BRAIN INJURY;
BRAIN PROTECTION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOTOXICITY;
IMMUNOCOMPETENT CELL;
IMMUNOREACTIVITY;
MALE;
NERVE;
NICK END LABELING;
NIGRONEOSTRIATAL SYSTEM;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PROTEIN INTERACTION;
PROTO ONCOGENE;
RAT;
ACTINS;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, CD147;
ANTIGENS, NEOPLASM;
ANTIGENS, SURFACE;
ANTIOXIDANTS;
AVIAN PROTEINS;
BLOOD PROTEINS;
CORPUS STRIATUM;
EXCITATORY AMINO ACID AGONISTS;
KAINIC ACID;
MALE;
MELATONIN;
MEMBRANE GLYCOPROTEINS;
MICROGLIA;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RATS;
RATS, SPRAGUE-DAWLEY;
SUBSTANTIA NIGRA;
TYROSINE 3-MONOOXYGENASE;
|
EID: 0034982924
PISSN: 08910618
EISSN: None
Source Type: Journal
DOI: 10.1016/S0891-0618(01)00109-0 Document Type: Article |
Times cited : (13)
|
References (48)
|